ALNY vs PFS · P/E 76, rev $1.29B vs P/E 16, rev $40.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Provident Financial Services Inc (PFS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Provident Financial Services Inc (PFS) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported PFS revenue for 2026-06-30 was $40.3M. Net income was $157.6M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. PFS currently screens at market cap $2.31B and trailing P/E 16.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PFS currently screens at market cap $2.31B and trailing P/E 16.0.
Not investment advice. Open the ALNY and PFS stock pages for the full models.
Not investment advice.